$22.88
+0.08 (+0.35%)
Open$22.51
Previous Close$22.80
Day High$22.89
Day Low$22.51
52W High$25.15
52W Low$16.52
Volume—
Avg Volume595.2K
Market Cap1.70B
P/E Ratio6.25
EPS$2.99
SectorPharmaceuticals
Analyst Ratings
Strong Buy
11 analysts
Price Target
+71.2% upside
Current
$22.88
$22.88
Target
$39.16
$39.16
$23.99
$39.16 avg
$41.33
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 359.60M | 334.57M | 296.49M |
| Net Income | 237.06M | 198.50M | 100.45M |
| Profit Margin | 65.9% | 62.6% | 33.9% |
| EBITDA | 152.84M | 135.10M | 161.71M |
| Free Cash Flow | — | — | 84.32M |
| Rev Growth | +7.5% | +7.5% | +12.4% |
| Debt/Equity | 0.22 | 0.22 | 0.49 |
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $948.45 | -2.72% | 36.1 | 913.24B |
| JNJ | Johnson & Johnson | $221.32 | -0.53% | 26.1 | 548.94B |
| MRK | Merck & Co. Inc. | $111.38 | -0.82% | 31.3 | 279.42B |
| PFE | Pfizer Inc. | $25.68 | -3.02% | 19.3 | 150.09B |
| BMY | Bristol-Myers Squibb Co | $56.16 | -0.16% | 17.0 | 120.08B |
| ZTS | Zoetis Inc | $82.83 | -5.13% | 21.5 | 57.37B |